Akebia Therapeutics, INC.
Doing business as C. T. CORPORATION SYSTEM (Previous Legal)
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents32
SAM.gov UEIYCMLJAJDXWC3
CAGE code5JD57
Incorporated inDE
LEI549300CBQEHMKEEGNX42
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
32 US patents granted 2012–2025, 12 of them in the five years to SEP 2025.
Pharmaceuticals 27Organic fine chemistry 3Biotechnology 1
- Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofUS 12,419,877 · granted SEP 23, 2025
- Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino] acetic acidUS 12,269,802 · granted APR 8, 2025
- Prolyl hydroxylase inhibitors and methods of useUS 11,883,386 · granted JAN 30, 2024
- Compositions and methods for treating anemiaUS 11,857,543 · granted JAN 2, 2024
- Compositions and methods for treating anemiaUS 11,844,756 · granted DEC 19, 2023
Newest 5 shown · Granted to Akebia Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Akebia Therapeutics, INC. | Cambridge | MA | — | ACTIVE |
WARN Act notices
- WARN notice effective APR 15, 2022 · 181 employees · Akebia Therapeutics, INC.
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
